cost benefit analysis of hepatitis c screening
The laboratory evaluation included tests for both hepatitis B and C. Tests for hepatitis C consisted of an alanine aminotransferase (ALT) test at a cost of $19.60 per test, an anit-HCV antibody screening test (EIA-2) costing $40.20, and a confirmatory recombinant immunoblot assay (RIBA) costing $148.90.